Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012 Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …
News
dr_susan_wood

Astellas Pharma Europe appoints new senior director

August 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood

Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …
Appointment

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012 Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
News
Avastin image

Avastin sees success in brain cancer trial

August 13, 2012 Research and Development, Sales and Marketing R&D, avastin, brain cancer

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …
News
Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012 Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …
News

Contract research news in brief

August 10, 2012 Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum

ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.
News

Pfizer signs drug profiling deal with Nodality

August 10, 2012 Research and Development, Sales and Marketing Lupus, Nodality, Pfizer, SCNP

Pfizer has signed a multi-year drug profiling deal with Nodality to help get the best from its autoimmune disease compounds. …
News
screen_shot_2012-08-10_at_10

Former Pfizer head Kindler joins Lux Capital

August 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kindler, Pfizer

Venture capital firm Lux Capital has appointed former Pfizer chairman and chief executive Jeff Kindler as a partner. Kindler will …
Appointment
Amanda Paxon image

Working Life: Amanda Paxon

August 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amanda Paxon, Boehringer Ingelheim, Working Life

 How did you find your way into your current role? Through a combination of good luck and hard work! I …
Feature

Amgen scraps pancreatic cancer drug

August 9, 2012 Research and Development, Sales and Marketing Amgen, GAMMA, Ganitumab, pancreatic

Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …
News

Cambridge University gains stem cell centre funding

August 9, 2012 Research and Development, Sales and Marketing Cambridge, MRC, Wellcome Trust, stem cell

The Wellcome Trust and the Medical Research Council are investing £8 million into a new stem cell research centre. The …
News
screen_shot_2012-08-09_at_11

NHS Board appointments

August 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS, government

Further Commissioning Support Unit (CSU) managing directors have been announced by the NHS Board Authority.
Appointment
screen_shot_2012-08-08_at_16

ABPI appoints UK pharma team to head VBP discussion

August 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, VBP

The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the …
Appointment
Astrazeneca image

AstraZeneca and BTG sepsis drug fails

August 8, 2012 Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis

AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …
News
charles-howeson

Appointments made to NHS property services

August 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Howeson, NHS

The company set up by the government to manage all the ex-PCT estate not transferred to providers (NHS Property Services), …
Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026